Syncom Formulations (India) Limited promoters and promoter group have voluntarily waived their entitlement to the final dividend of ₹0.10 per share proposed for FY26. This decision reduces the total cash outflow by ₹4.75 crore, leaving a net payable amount of ₹4.64 crore for other shareholders.

The waiver applies to 47,53,47,599 equity shares held by the promoter entities, representing approximately 50.5% of the company's total outstanding shares. The Board of Directors had recommended the dividend subject to shareholder approval at the ensuing Annual General Meeting.

Dividend Waiver Details

The company disclosed that the waiver is voluntary, unconditional, and involves no consideration or benefit from the company to the concerned shareholders. The following table outlines the impact on the total dividend payout:

What the Numbers Show

Promoters hold exactly 50.57% of the total equity base (47,53,47,599 out of 94,00,00,000 shares). By waiving their share, they effectively reduce the company's immediate liquidity requirement for dividend distribution by more than half. The remaining liability falls entirely on the minority shareholders, who hold 46,46,52,401 shares.

This intimation was filed under Regulation 30 of the SEBI (LODR) Regulations, 2015, and Clause 118 of the Company’s Articles of Association. The final dividend remains subject to declaration by members at the Annual General Meeting.

Syncom Formulations has fixed September 23, 2026, as the record date for determining shareholder eligibility for its final dividend for FY26. The company proposes a payout of ₹0.10 per equity share of face value ₹1 each.

The dividend declaration is subject to approval by members at the company’s 38th Annual General Meeting (AGM). The AGM is scheduled to be held on September 30, 2026, at 2:00 pm via video conferencing or other audio-visual means.

Dividend Details

The final dividend relates to the financial year ended March 31, 2026. Shareholders on record as of September 23, 2026, will be eligible to receive the payout if approved by shareholders.

Waiver Process

Shareholders who wish to voluntarily waive their entitlement to the dividend, either in full or in part, must submit a duly filled and signed Dividend Waiver Form. The form is available on the company’s website.

Completed forms must be sent to the company or its Registrar and Transfer Agent (RTA) on or before September 26, 2026. This deadline ensures the waiver is processed before the dividend payment date.

Regulatory Disclosure

The announcement was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act, 2013.